56 weeks max with breaks Injection Site: Subcutaneous preferred for consistent delivery Goal Phases: Recomp, injury recovery, performance support Example Cycle (4 Weeks): Weeks 14: 15 mcg IGF-1 LR3 post-workout, 5x/week Paired with: Swolverine ZMT for hormone and sleep support, Collagen, and clean carb/protein intake Stack potential: MK-677 (low dose), or run as a solo peptide for clean recovery Both men and women should avoid exceeding 8 weeks of continuous IGF-1 LR3 use without taking a break, as prolonged elevation may increase insulin desensitization or desensitize receptors
The practical result is accelerated healing from both acute injuries and chronic repetitive stress
John GB, Gallardo TD, Shirley LJ, Castrillon DH
Insulin and other glucose-lowering drugs may need adjustment to reduce hypoglycemia risk
How to test and treat small intestinal bacterial overgrowth: an evidence-based approach
Tirzepatide is administered subcutaneously once weekly, with peak plasma concentration occurring 2472 hours post-injection